![A checklist for clinical trials in rare disease: obstacles and anticipatory actions—lessons learned from the FOR-DMD trial | Trials | Full Text A checklist for clinical trials in rare disease: obstacles and anticipatory actions—lessons learned from the FOR-DMD trial | Trials | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13063-018-2645-0/MediaObjects/13063_2018_2645_Fig3_HTML.png)
A checklist for clinical trials in rare disease: obstacles and anticipatory actions—lessons learned from the FOR-DMD trial | Trials | Full Text
1 mCTA TEMPLATE(version 8.0) May 2017 MODEL CLINICAL TRIAL AGREEMENT FOR PHARMACEUTICAL INDUSTRY SPONSORED, PHASE [II or III]
![Study selection of cancer clinical trials using PROMs and reporting... | Download Scientific Diagram Study selection of cancer clinical trials using PROMs and reporting... | Download Scientific Diagram](https://www.researchgate.net/publication/351106697/figure/fig1/AS:1017076785356800@1619501410187/Study-selection-of-cancer-clinical-trials-using-PROMs-and-reporting-ethnic-group-data.png)